Erypharm has made a breakthrough in the process of producing cRBCs
and is committed to clinical development and industrialization of this new drug
2011 First Academic Proof of concept (Blood journal) : First injection into human of cRBCs produced in artisanal conditions. Demonstration of the validity of the concept and of the higher efficiency of cRBCs compared to native red blood cells.
This website is a work in progress and should be finalized soon.